In bladder atony, the desire to void may not be realized until bladder volumes of 500 to 600 ml. are reached. 11 In chronic urinary retention due to urethral obstruction, bladder volume may ...

More information: Yiming Ding et al, Relationship between dietary patterns and overactive bladder: a cross sectional study of NHANES 2013 to 2023, Frontiers in Nutrition (2025).

Alzheimer's disease (AD) is a debilitating neurodegenerative condition that affects a significant proportion of older people worldwide. Synapses are points of communication between neural cells ...

Prostate and bladder cancer in men can be prevented with the right lifestyle practices. Around Father's Day 2025 is a good time to learn such tips. | Health ...

Even so, 30% of people with bladder cancer have no identifiable risk. Fortunately for you, a noninvasive cancer was found that was less than 3 cm, which is the best possible result for bladder cancer.

The U.S. Food and Drug Administration has approved UGN-102 (mitomycin intravesical solution) for the treatment of adult patients with recurrent low-grade intermediate-risk non-muscle invasive bladder ...

Health Warning! Peeing in the shower can severely harm your bladder and pelvic health TOI Lifestyle Desk / etimes.in / Jun 16, 2025, 14:30 IST ...

The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's drug to treat a type of bladder cancer, providing an alternative treatment as opposed to traditional surgical procedures.

There are new questions about who — in the rubber industry — is affected by bladder cancer. A former Sumitomo Rubber employee is coming forward and voicing concern about his diagnosis.

Botox treats certain bladder problems in adults and in children. To learn more about the specific conditions it’s used for, see the “Which bladder conditions does Botox treat?” section.

Scientists at UC San Francisco have found a way to identify and possibly treat a mysterious type of bladder cancer that affects up to 1 in 4 cases.

The disease, a type of non-muscle invasive bladder cancer, affects about 82,000 people in the U.S. each year, with around 59,000 experiencing a recurrence, according to UroGen.